ATLANTA, June 8, 2011 /PRNewswire/ — Elekta has collaborated
with the National Comprehensive Cancer Network® (NCCN®) to
integrate the NCCN Clinical Practice Guidelines in Oncology (
NCCN Guidelines™) into Elekta’s MOSAIQ® Oncology
Information System. The collaboration offers Elekta users real-time
access to NCCN’s evidence-based clinical content directly from
within the MOSAIQ patient record.
“The NCCN Guidelines are widely recognized as the
standard for clinical policy in oncology in the United States and
increasingly internationally,” says William T. McGivney, PhD, Chief
Executive Officer, NCCN. “It is important that the NCCN Guidelines
recommendations be available to clinicians in electronic
decision-assist tools. The integration of NCCN Guidelines into
MOSAIQ is a critical step in enhancing the evidentiary basis of
clinical decision-making in oncology.”
The integration of the NCCN Guidelines in MOSAIQ eliminates the
need for clinicians to change screens and login to separate
systems, or to purchase the license separately. Now, from an open
patient chart, MOSAIQ users simply right click to view the NCCN
Guidelines pertaining to an individual patient’s cancer diagnosis.
Easy access to the NCCN Guidelines results in real and measureable
time-savings and faster, more informed decision making.
“This is just one more example of Elekta taking the leadership
position in refining the capabilities of its electronic medical
record (EMR) solution,” says Todd Powell, Executive Vice President,
Elekta Software. “Most recently, MOSAIQ became the only
oncology-specific, comprehensive EMR certified for Meaningful Use
under the federal government’s HITECH Act. Now, with NCCN, we have
significantly enhanced the ability for clinicians to use MOSAIQ as
a clinical decision-making tool.”
The NCCN Guidelines are available now wit
‘/>”/>